The bridge program is specifically for patients seeking chronic weight management, not diabetes treatment
Moving forward, it is important for clinicians to be aware of the possibility of known or novel injection-site reactions in response to GLP-1RAs
The short answer is yes, it is generally considered safe to switch from tirzepatide to semaglutide, provided the transition is managed by a licensed healthcare professional
And if you arent familiar with the compound, let me introduce you
Melanotan-1 does not tan skin in complete absence of UV
In case you're not sure exactly how they work, GLP-1 agonists mimic the GLP-1 hormone receptor, which is created in the small intestine and regulates the way food passes through the stomach